Drug Type Small molecule drug |
Synonyms Bixalomer (JAN/USAN/INN), AMG-223, AMG223 + [5] |
Target |
Mechanism Phosphates modulators(Phosphates modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (30 Mar 2012), |
Regulation- |
Molecular FormulaC19H45ClN6O |
InChIKeyUHTZABZWCSJMDY-UHFFFAOYSA-N |
CAS Registry851373-13-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperphosphatemia | JP | 30 Mar 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 3 | JP | 01 Jan 2010 | |
Uremia | Phase 3 | JP | 01 May 2009 | |
Kidney Failure, Chronic | Phase 2 | - | 01 Mar 2008 | |
Tumoral Calcinosis, Hyperphosphatemic, Familial | Phase 2 | - | 01 Mar 2008 | |
Kidney Diseases | Phase 2 | US | 01 Jun 2006 |
NCT01742611 (Pubmed) Manual | Phase 3 | 105 | xmdmyqumtl(cslhfmcpsm) = ltcfcdhijj rcwwdnvihp (tbbauqofom ) View more | Positive | 01 Apr 2017 | ||
Not Applicable | - | 114 | pvyibhwszb(plnfcxaetb) = vbpzbvbuof jocqfnfcwd (sbaklhyndz ) View more | Positive | 05 Nov 2013 | ||
pvyibhwszb(plnfcxaetb) = ueelnepnzt jocqfnfcwd (sbaklhyndz ) View more |